Anavex Life Sciences Corp. (AVXL) vs Fortress Biotech, Inc. (FBIOP)
A side-by-side comparison of Anavex Life Sciences Corp. and Fortress Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVXL
Anavex Life Sciences Corp.
$1.64HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT
FBIOP
Fortress Biotech, Inc.
$17.75HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT
Total return — AVXL vs FBIOP
growth of $100 · dividends reinvested · last 9yAVXL -57.8% (-9.1%/yr)FBIOP +66.3% (+5.8%/yr)FBIOP compounded faster over this window
AVXL FBIOP
AVXL vs FBIOP: by the numbers
- •AVXL is the larger company ($152M vs $140M market cap).
- •FBIOP is profitable (163.32% net margin) while AVXL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AVXL | FBIOP |
|---|---|---|
| P/E ratio | N/A | 6.62 |
| Forward P/E | N/A | 6.96 |
| P/S ratio | N/A | 2.04 |
| P/B ratio | 1.35 | 0.85 |
| FCF yield | N/A | 90.06% |
Profitability
| Metric | AVXL | FBIOP |
|---|---|---|
| Gross margin | 0.00% | 62.53% |
| Operating margin | 0.00% | -111.00% |
| Net margin | 0.00% | 163.32% |
| ROE | -21.38% | 68.12% |
| ROIC | -27.25% | -10.85% |
Growth (annualized)
| Metric | AVXL | FBIOP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 5.39% |
| Total return CAGR (5Y) | -37.74% | 0.05% |
Frequently asked
- Is AVXL or FBIOP more profitable?
- FBIOP runs the higher net margin — AVXL at 0.00% versus FBIOP at 163.32%.
- How have AVXL and FBIOP total returns compared?
- Over the past 5 years, AVXL delivered -37.74% and FBIOP delivered 0.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fortress Biotech P/E ratioAnavex Life Sciences ROEFortress Biotech ROEAnavex Life Sciences operating marginFortress Biotech operating marginAnavex Life Sciences revenue growthFortress Biotech revenue growthAnavex Life Sciences free cash flowFortress Biotech free cash flow
Anavex Life Sciences & Fortress Biotech appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.